Photo of Daryn Grossman

Daryn A. Grossman is Managing Partner of the Firm. She serves as the head of the Life Sciences Group and is the former co-chair of Proskauer’s global Corporate Department and former co-head of the Technology, Media & Telecommunications Group.

For over 20 years, Daryn has designed and negotiated complex technology and intellectual property transaction structures, including strategic alliances, licensing, technology development and outsourcing transactions. Her clients include a wide range of life sciences, cloud computing, digital media, Internet, software, electronics, luxury goods, retail, fashion, entertainment, telecommunications and clean technology companies.

Daryn’s practice also focuses on technology mergers, acquisitions, sales and spinoffs. She represents both growth and mature companies, and counsels venture capitalists and strategic investors in evaluating intellectual property portfolios in connection with private equity investments, public offerings and mergers and acquisitions. Daryn often counsels boards of directors and management teams in navigating the critical commercial and legal issues surrounding product development and exploitation and risk mitigation.

Chambers USA describes Daryn as “skilled and resourceful.” IAM Patent writes: “In the IP monetization area, there is nothing crack negotiator Daryn Grossman can’t do,” adding that she has “a command of all deal types across the IP commercialization spectrum…she can go toe to toe with anybody. She just gets deals done.” Daryn has also been recognized by such publications as The Legal 500 United StatesBest Lawyers in America and IAM Licensing.

Daryn participates in the management of the firm in various capacities. In addition to her current roles, she previously has served on the firm’s Hiring Committee, Business Development Committee and Lateral Acquisition Committee. She has also served as a partner liaison to the Proskauer Women’s Alliance and as the Administrative Partner for the Corporate Department.

Daryn is a frequent lecturer on entrepreneurship and issues related to technology, licensing and intellectual property law.

For many scientists, the most satisfying part of producing a lengthy article (aside from the hoped-for Nobel prize) is the moment when the page proofs are finally out the door to the publisher and the thought occurs they they will never have to look at the article again. But a new requirement that authors post an article abstract on the Wikipedia online encyclopedia may have them revisiting their work, or at least an abstract of it, a bit sooner than anticipated.

The science journal RNA Biology has announced new guidelines that require authors to prepare and submit an abstract of their article accepted for publication in the new RNA Families section of the Journal for posting on the Wikipedia online encyclopedia. According to an article in Nature magazine, this is the first such requirement ever imposed on authors by a science publication. Once the article is accepted for publication, the guidelines require the author to upload the abstract to Wikipedia.

Disputes over the enforceability of Web site modifications to an agreement, based on claims of unconscionability, typically involve a consumer opposing the enforcement efforts of commercial party. An example of such a case is Comb v. PayPal, 218 F.Supp. 2d 1165, 1174 (N.D.Cal. 2002), in which the district court refused to enforce a provision in the PayPal agreement with users that allowed PayPal to modify the terms of the agreement without notice, by posting the modified terms on its Web site.

Unlike that paradigm case, the parties in Margae v. Clear Link Technologies, LLC, 2008 U.S. Dist. LEXIS 46765 (D. Utah June 16, 2008), were commercial parties involved in transactions involving affiliate marketing and search engine optimization services.